Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Guanxin Danshen Dripping Pills for coronary artery disease with blood-stasis syndrome
ChiCTR-TRC-11001839Phase 4Recruiting
- Sponsor
- Xiyuan Hospital
- Start
- Oct 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of Compound Danshen in coronary arteriosclerosis and blood stasis syndrome (BSS) (2 arms), sponsored by Xiyuan Hospital. Primary endpoints: Symptoms, Physical signs and 3 more. Started Oct 2011; status: recruiting.
02
Drugs
Compound Danshen
03
Conditions
coronary arteriosclerosisblood stasis syndrome (BSS)
Beyond the preview
Go deeper on ChiCTR-TRC-11001839.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-11001839.